KLK3 and prostate cancer: The PSA screening test has been in use for decades with a sensitivity of 21% and specificity of 91% for prostate cancer screening, but more accurate and newer tests including the prostate health index (PHI) and PCA3 may become the recommended initial screening test of choice [9].